PI-LAB-2026-196

Orforglipron, Independent Lab Report

Orforglipron 24mg · Cardinal Metabolic Clinic

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 98.6% met the stated ≥99% claim. Content measured 99.7% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
98.6%

Label claimed ≥99%

Content accuracy
99.7%

23.93mg measured against 24mg claimed

Test recency
Current cycle

Published 3 months ago

Specimen PI-LAB-2026-196 Tested by Chelsea Analytical Group 10 samples tested from this company Purity & Testing score 98/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 99% 98.6% Within analytical tolerance
Identity (MS) Orforglipron Confirmed Matches label
Content 24 mg 23.93 mg Within 5% of label

Methodology & chain of custody

Reversed-phase HPLC purity analysis with UV detection at 214nm.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Chelsea Analytical Group. See our full testing methodology.

Lot / batch
R7108-26
Purchased
Analysed
Published
Laboratory
Chelsea Analytical Group
Test type
Purity, identity & content

Original laboratory report: PI-LAB-2026-196-report.pdf (document delivery arrives with the production storage backend)

More Tests, Cardinal Metabolic Clinic

Retatrutide
Purity 93.7% Verified
Tirzepatide
Purity 99.2% Verified
Orforglipron
Purity 98.2% Verified

More Tests, Orforglipron

Orforglipron Meridian Health Direct
Purity 98.1% Verified
Orforglipron Verity Research Chemicals
Purity 98.3% Verified
Orforglipron Cardinal Metabolic Clinic
Purity 98.2% Verified